Residential College | false |
Status | 已發表Published |
ZY-444 inhibits the growth and metastasis of prostate cancer by targeting TNFAIP3 through TNF signaling pathway | |
Han, Meng-Ting1,2; Pei, Hua2; Sun, Qi-Qi2; Wang, Cheng-Long2; Li, Peng3; Xie, Ya-Ya1; Cao, Li-Jun1; Zhang, Xing-Xing2; Sun, Zhen-Liang2 | |
2023-04 | |
Source Publication | American Journal of Cancer Research |
Volume | 13Issue:4Pages:1533-1546 |
Document Type | Journal article |
Collection | Institute of Chinese Medical Sciences |
Corresponding Author | Zhang, Xing-Xing; Sun, Zhen-Liang |
Affiliation | 1.Anhui University of Science and Technology 2.Fengxian Hospital Affiliated to Anhui University of Science and Technology 3.University of Macau |
Recommended Citation GB/T 7714 | Han, Meng-Ting,Pei, Hua,Sun, Qi-Qi,et al. ZY-444 inhibits the growth and metastasis of prostate cancer by targeting TNFAIP3 through TNF signaling pathway[J]. American Journal of Cancer Research, 2023, 13(4), 1533-1546. |
APA | Han, Meng-Ting., Pei, Hua., Sun, Qi-Qi., Wang, Cheng-Long., Li, Peng., Xie, Ya-Ya., Cao, Li-Jun., Zhang, Xing-Xing., & Sun, Zhen-Liang (2023). ZY-444 inhibits the growth and metastasis of prostate cancer by targeting TNFAIP3 through TNF signaling pathway. American Journal of Cancer Research, 13(4), 1533-1546. |
MLA | Han, Meng-Ting,et al."ZY-444 inhibits the growth and metastasis of prostate cancer by targeting TNFAIP3 through TNF signaling pathway".American Journal of Cancer Research 13.4(2023):1533-1546. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment